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Abstract. In interphase cells, a-casein kinase I (et-CKI) 
is found associated with cytosolic vesicular structures, 
the centrosome, and within the nucleus. To identify the 
specific vesicular structures with which a-CKI is associ- 
ated, established cell lines and primary rat neurons 
were immunofluorescently labeled with an antibody 
raised to a-CKI. In nonneuronal cells, a-CKI colocal- 
izes with vesicular structures which align with microtu- 
bules and are partially coincident with both Golgi and 
endoplasmic reticulum markers. In neurons, o~-CKI 
colocalizes with synaptic vesicle markers. When synap- 
tic vesicles were purified from rat brain, they were 
highly enriched in a CKI, based on activity and immu- 
noreactivity. The synaptic vesicle-associated CKI is an 
extrinsic kinase and was eluted from synaptic vesicles 
and purified. This purified CKI has properties most 
similar to o~-CKI. When the activities of casein kinase I 
or II were specifically inhibited on isolated synaptic 
vesicles, CKI was shown to phosphorylate a specific 
subset of vesicle proteins, one of which was identified 
as the synaptic vesicle-specific protein SV2. As with 
ot-CKI, the synaptic vesicle CKI is inhibited by phos- 
phatidylinositol 4,5-bisphosphate (PIP2). However, syn- 
thesis of PIP2 was detected only in plasma membrane- 
containing fractions. Therefore, PIP2 may spatially 
regulate CKI. Since PIP2 synthesis is required for secre- 
tion, this inhibition of CKI may be important for the 
regulation of secretion. 
C 
ELLS transport proteins and lipids throughout their 
cytoplasm using small vesicles containing specific 
integral membrane proteins (2-5, 13, 24, 35, 38, 52, 
58, 62, 72-74). This transport system is microtubule depen- 
dent and requires motor proteins (16, 19, 31). In this pro- 
cess, vesicles bud from donor membranes and are shunted 
to  specific acceptor membranes  where the vesicles fuse 
and release their contents. These general events can be di- 
vided into constituitive and regulated pathways (13, 17, 24, 
35, 41, 65, 72-74). Although distinct,  the two pathways ap- 
pear  to have similar  components in common.  A  typical 
constitutive  pathway would be the  shuttling  of vesicles 
within and between the endoplasmic reticulum, the Golgi 
organelle, and the plasma membrane. The movement and 
CaE+-dependent fusion of synaptic vesicles provides an ex- 
ample of a regulated secretory pathway. 
Stidhof  and  Jahn  (74)  have  divided  synaptic  vesicle 
transport,  docking,  exocytosis, and  recycling into  seven 
discrete stages. Many of the factors involved in these pro- 
cesses and their respective roles have now been identified. 
For  example,  two  vesicle-associated  proteins,  synapto- 
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physin and synaptobrevin, and two proteins integral to the 
plasma membrane, syntaxin and neurexin are involved in 
docking (4, 5, 10, 11, 26, 62, 68, 75).  Synaptotagmin,  an- 
other vesicle integral membrane protein, is thought to act 
in both the positioning of vesicles at the plasma membrane 
and the Ca2+-dependent step of the fusion process (12, 22, 
34, 37, 55, 60, 61). Finally, the SNAPs (N-ethylmaleimide- 
sensitive factor-associated proteins)  have been linked to 
vesicle targeting and fusion (11, 15, 35, 71, 77). 
Within each of these stages, the myriad of processes in- 
volved are extensively regulated. Evidence exists showing 
that  G-proteins  (16-18, 23, 41, 42),  phosphoinositide ki- 
nases (23, 45-48, 69), phospholipase D (23, 30) and protein 
kinases (9, 12, 14, 27, 33, 34, 36, 51, 52, 59, 70) play regula- 
tory  roles  in  vesicular  trafficking,  exocytosis, and  long 
term  potentiation.  However, these  mechanisms  are  not 
well defined. Moreover, it is likely that many of the ki- 
nases and their respective substrates remain to be defined. 
A  growing number  of protein kinases  have been impli- 
cated in the regulation of neuronal transmission. Evidence 
demonstrates that a-CaM kinase II is involved in regula- 
tion of long-term potentiation and learning (8, 9, 27, 51, 57, 
70).  In addition, a number of other protein kinases have 
been localized to the synaptosome such as cAMP-depen- 
dent protein kinase, protein kinase C, src tyrosine kinase, 
a proline-directed protein kinase, and casein kinase II (12, 
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nases with synaptic vesicles is less defined, but evidence 
suggests that CAM kinase (9)  and an src tyrosine kinase 
(53)  directly associate  with  synaptic  vesicles.  As  men- 
tioned above, protein phosphorylation events appear to be 
involved in regulating synaptic transmission (8, 14, 27, 57, 
70).  Therefore, the identification and characterization of 
additional protein kinases associated with synaptic vesicles 
could provide insight into not only the regulatory cascade 
involved in vesicle movement and fusion, but potentially 
also  the  constituitive vesicular  trafficking pathways be- 
cause of the functional conservation between the two. The 
association of a protein kinase with secretory vesicles sug- 
gests a role in vesicular trafficking. We describe here the 
localization and biochemical characterization of a  casein 
kinase I which is associated with synaptic vesicles. 
Materials and Methods 
Antibodies 
The 36-kD a-casein kinase I (et-CKI)  1  antibodies (21) and the type I and II 
PIP 5-kinase antibodies (7, 50) were prepared  as previously described. 
The following antibodies were kind gifts: SV-2 mouse monoclonal anti- 
body from Dr. Erik Schweitzer (UCLA, Los Angeles, CA), syntaxin poly- 
clonal  and  synaptotagmin  monoclonal  antibodies  from  Dr.  Richard 
Scheller (Stanford University, Stanford, CA), syntaxin monoclonal anti- 
bodies from Dr. Colin Barnstable (Yale University, New Haven, CT), syn- 
aptophysin monoclonal antibody from Dr. Pietro DeCamilli (Yale Uni- 
versity, New Haven, CT). BiP monoclonal antibody was from Dr. David 
Bole  (University of Michigan, Ann Arbor,  MI).  13-COP mouse mono- 
elonal was from Dr.  Thomas E.  Kreis (EMBL, Heidelberg,  Germany). 
N-CAM monoclonal antibody was purchased from Sigma Chem. Co. (St. 
Louis, MO).  Synaptophysin antibody  was  also  purchased from Boeh- 
ringer-Maunheim Corp.  (Indianapolis, IN).  Secondary antibodies were 
purchased from Jackson Immunoresearch (West Grove, PA). 
Cell Culture and Immunofluorescence Labeling 
CHO and LLC-PK (porcine kidney) cells were grown in Ham's F-10 or 
DME, respectively, with 10% FBS. PC-12 ceils were grown in DME with 
10% FBS and 5% horse serum. All cells were grown at 37°C with 5% CO2. 
PC-12 cells were differentiated by addition of nerve growth factor and 
dibutyl-cyclic adenosine monophosphate. After 2 d of treatment, growth 
cones were readily apparent and, after 6 d, extensive axonal arrays had de- 
veloped. For immunofluoreseence, cells were grown on glass coverslips 
and fixed with -20°C methanol. Nonspecifie sites were then blocked with 
3% BSA in PBS (pH 7.4) for 60 rain at room temperature or overnight at 
4°C.  Coverslips were incubated with primary antibodies for 60  rain  at 
room temperature or overnight at 4°C and then washed with 1%  BSA/ 
PBS. Texas-red donkey anti-mouse IgGs and fluorescein isothiocyanate- 
conjugated goat anti-rabbit IgGs (Jackson Immunoresearch) at a dilution 
of 1:1,000 in 3% BSA/PBS were then applied to the coverslips and incu- 
bated for 60 rain at room temperature. Coverslips were washed as before, 
and then mounted on slides with 90% glycerol/PBS supplemented with 1 
mg/ml p-phenylenediamine and diazobicyclo-[2,2,2]-octane (DABCO) at 
a  concentration of 100 mg/ml. Sympathetic ganglia were isolated from 
newborn rat pups and grown as previously described (1). For immunoflu- 
oreseence, the neurons were grown on lamin-coated glass eoverslips and 
fixed in one of two ways: cold methanol, as described above, or parafor- 
maldehyde fixation. For paraformaldehyde fixation, neurons were initially 
rinsed in 3"PC  PBS, incubated with 4%  paraformaldehyde/4% sucrose/ 
PBS for 10-20 min at 23°C and extracted with 1% Triton X-100 in PBS for 
10 rain. These neurons were treated for immunofluorescence as above. 
Primary antibodies were prepared for immunofluorescenee at the fol- 
lowing concentrations in 3% BSA/PBS: ct-CKI rabbit polyclonal, 10 p,g/ 
1. Abbreviations used in this paper, ct-CKI, a-casein kinase I; DFP, diiso- 
propylfluorophosphate; PIP2, phosphatidylinositol 4,5-b/sphosphate; PIP, 
phosphatidylinositol 4-phosphate; SGP, sucrose gradient pellet. 
ml; [3-tubulin mouse monoclonal (Amersham, Corp. Arlington Heights, 
IL),  1:1,000  dilution of ascites; 13-COP mouse monoclonal (Kreis), l:100 
dilution of aseites; BiP rat monoclonal (Bole), 1:25 dilution of ascites; SV-2 
(Sehweitzer), 1:20 dilution of ascites; synaptophysin rabbit polyclonal, 10 
p~g/ml; Synaptophysin mouse monoclonal (deCamilli), 1:25 dilution from 
ascites; Synaptophysin mouse monoclonal (Boehringer-Mannheim),  2 v.g/ml. 
As negative controls, 10 v~g/ml of CKI antibody in 3% BSA/PBS was 
preincubated with CKI-Sepharose beads or pure, denatured CKI and then 
used for immunofluorescence as above. Cells were observed with a Zeiss 
Axiovert 135, or a  Nikon Optiphot equipped with an MRC Lasersharp 
confocal imaging system (Bio-Rad Labs., Hercules, CA). 
Synaptic Vesicle  Isolation 
Synaptic vesicles were isolated from rat cerebral cortex by the method of 
Huttner et al. (49), except for the following changes. Fresh rat brains were 
homogenized in cold "buffered sucrose" (320 mM sucrose, 4 mM Hepes- 
NaOH, pH 7.3, 1 mM EDTA, 0.1 mM EGTA, 10 mg/ml leupeptin, 0.1 mM 
PMSF, 0.1 mM diisopropylfluorophosphate [DFP]). The remaining meth- 
ods were identical to that of Huttner et al. (49) except that all buffers con- 
tain the following: 1 mM EDTA, 0.1 mM EGTA, 10 p,g/ml leupeptin, 0.1 
mM PMSF, and 0.1 mM DFP. The resulting fractions were defined using 
the Huttner et al. nomenclature (49). In some preparations, the extensively 
washed, crude synaptosomal fraction (P2') was further purified by discon- 
tinuous Ficoll density gradient sedimentation. For Ficoll density gradient 
sedimentation, 5 ml of the P2 fraction (30 mg protein) was applied to a 25- 
ml discontinuous Ficoll gradient consisting of 10 ml of 13%, 5 ml of 9%, 
and 10 ml of 4% Ficoll (wt/vol). This was centrifuged for 50 min at 23,000 
rpm in a  SW28 rotor  (Beckman Instrs., Fullerton,  CA). Intact synapto- 
somes banded in the 9%  Ficoll layer and were isolated by fractionating 
with a pipette. The 4% Ficoll fraction (F1) and the 9-13% Ficoll fraction 
(F2)  were assayed for CKI and synaptophysin by Western blotting. The 
synaptic vesicles were released from the purified, washed synaptosomes by 
low osmolarity lysis and Dounce homogenization. The crude synaptic vesi- 
cles (LP2 fraction) were isolated by differential centrifugation (49).  The 
LP  2 fraction (4 rod) was further purified using continuous sucrose (50-800 
raM, 25 ml) velocity gradient sedimentation. The gradient was centrifuged 
for 5 h at 65,000 g. The synaptic vesicles band at ~400 mM sucrose while 
most membranes sediment at the bottom of the gradient (sucrose gradient 
pellet, SGP). The band of synaptic vesicles (fractions 4-9) was pooled and 
concentrated by centrifugation. This synaptic vesicle fraction was further 
analyzed by Nycodenz equilibrium sedimentation. The  synaptic vesicle 
pool in 4 ml of 5% (wt/vol) Nycodenz was loaded onto a 10-30% 25-ml Ny- 
codenz gradient. This was centrifuged for 18 h at 22,000 rpm in a Beckman 
SW28 rotor, and 20 fractions of 1.5 ml each were collected. The SGP was 
washed by centrifugation and further homogenized with ten up-and-down 
strokes of a glass-on-glass  Dounee homogenizer. This was followed by ten 
passages through a 27-gauge needle. This homogenate was centrifuged at 
10,000 g for 15 rnin. The supernatant was analyzed by sucrose velocity gra- 
dient sedimentation, as above, or by equilibrium density gradient sedimen- 
tation on a 7-28% (wt/vol) Nycodenz gradient, centrifuged 18 h in a SW28 
rotor at 22,000 rpm and fractionated as above. 
Electron Microscopy 
Subcellular fractions were fixed in suspension by addition of glutaralde- 
hyde to a  final concentration of 2%. The fLxed membranes were  sedi- 
mented and prepared for transmission electron microscopy according to 
Huttner et al. (49). 
Western Blotting 
For blotting, cells were lifted from culture dishes with PBS containing 2 
mM EDTA, and lysed in hot Laemmli SDS-sample buffer. Protein con- 
centration was determined as before (21). Proteins were then separated 
on a 7-15% SDS-PAGE and transferred to nitrocellulose. The membrane 
was blocked in PBS containing 5% nonfat dry milk and 0.05% Tween-20. 
Next, the membrane was incubated with 10 v,g/ml affinity-purified CKI 
antibody in PBS with 3%  BSA and 0.05%  Tween-20 for 2  h  at 23°C. 
Bound antibody was detected by incubating the membrane for 1 h with 
12SI-protein A  (Amersham, 2 x  10  s cpm/ml) in PBS, 3% BSA and 0.05% 
Tween-20. The nitrocellulose was subsequently exposed to X-ray film. 
Purification of the 36-kD CKI  from Synaptic Vesicles 
The 36-kD CKI was purified from the LP2 membrane fraction of 200 rat 
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fered sucrose (49) was extracted by addition of dry KC1 to a final concen- 
tration of i  M. This solution was gently stirred for 30 rain on ice and then 
centrifuged for 2 h at 230,000 g. The supernatant was dialyzed against 0.15 M 
NaC1,  10  mM sodium phosphate, pH 7.5,  2  mM dithiothreitol, I  mM 
EDTA, 0.1 mM PMSF and 0.1 mM DFP (buffer A). This was applied to a 
15-ml phosphocellulose column, washed with two column volumes of 
buffer A containing 250 mM NaC1, and eluted with a 0.25-1.0 M NaC1 gra- 
dient. The column fractions were assayed using phosvitin and casein as 
substrates. Two peaks of kinase activity elnted at 0.54 and 0.72 M NaCI, 
respectively. The first peak of kinase activity corresponded to the 36-kD 
CKI by Western blotting and was pooled, concentrated, and applied to a 
Superose 12 column (Pharmacia LKB Bi), equilibrated with buffer A con- 
taining 0.5 M NaC1 at a flow rate of 0.5 ml/min. Fractions were collected 
every 2 min starting 60 min after injection of sample. The column was 
standardized by the elution of calibration markers shown in Fig. 7. The 
peak of the 36-kD CKI activity was pooled and dialyzed into 50 mM KC1, 
10 mM Tris, pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, and 0.1 mM PMSF 
(buffer B). 
Kinase Assays and Inhibition of CKI Activity 
CKI was assayed as described previously using a-casein or phosvitin as 
substrates (6, 20, 21). Briefly, protein phosphorylation was initiated with 
the addition of 50 raM Tris, pH 7.5, 5 mM MgCI2, 50 ram [~/-32p]ATP (30 
Ci/mol; final concentrations). When inhibitors were used, they were added 
before ATP. For determination of kinase  activity towards endogenous 
substrates on purified synaptic vesicles, the vesicles were dialyzed into 
buffer B and the above ATP-containing buffer was added to initiate the 
reaction. For antibody inhibition, affinity-purified CKI antibody in buffer 
B was combined with synaptic vesicles and incubated 12 h on ice. After 
addition of ATP, the reactions proceeded for 5-15 rain (linear range of 
phosphorylation) and were then quenched with four times concentrated 
Laemmli sample buffer or 500 mM EDTA to 5 mM (for subsequent im- 
munoprecipitation experiments, see below). Proteins were separated by 
7-15 % SDS-PAGE and bands corresponding to casein, phosvitin or other 
substrates were excised and scintillation counted using the 32p channel. 
Phosphatidylinositol 4-phosphate 5-kinase assays were done as previously 
described (7, 50). 
Immunoprecipitation of  Small Synaptic Vesicles 
Immunoprecipitation protocol was adapted from Schweitzer et al.  (67). 
100 I~g of synaptic vesicles were used for immunoprecipitation reactions. 
Each reaction was supplemented with either 50  p,g normal mouse sera 
(negative control, Jackson Immunoresearch) or 50 Ixg SV2 ascites and 
placed on a rotator at 4°C for 1 h. 10 Ixg of rabbit anti-mouse IgG was 
then added to the reactions and incubated on rotator for an additional 1 h 
at 4°C. Finally, the reactions were each supplemented with 50 mg Pan- 
sorbin (Calbiochem-Novabiochem Corp., La Jolla, CA) and incubated as 
before. The Pansorbin was then pelleted with a 1-min spin at 16,000 g in a 
microfuge and in some instances the resultant pellet was washed twice 
with 500 I~1 PBS or Hepes-buffered saline as detailed in the text or figure 
legend. Immunoprecipitate pellets were resuspended in Hepes-buffered 
saline in a  volume equivalent to their respective supernatants. All the 
samples were then supplemented with 4×  SDS Laemmli sample buffer 
and boiled for 10 min. In certain instances, synaptic vesicles were first 
phosphorylated as described above for subsequent immunoprecipitation 
experiments. 
In the studies identifying SV2 as a substrate, both phosphorylated and 
unphosphorylated  synaptic  vesicles  were  immunoprecipitated  as  de- 
scribed above but in the presence of 0.5% Triton X-100 during the actual 
immunoprecipitation or immediately before the pellet wash steps. The re- 
sultant immunoprecipitate pellets and supernatants were then analyzed by 
SDS-PAGE and autoradiography or Western blotting with the SV2 anti- 
bodies. 
Results 
Immunofluorescent Localization of CKI in 
Nonneuronal and Neuronal Cells 
In all nonneuronal cells stained with the ot-CKI antibodies, 
the kinase is found associated with cytosolic vesicular struc- 
tures (21). The vesicular staining in flat, adherent cells was 
often distinctly oriented and aligned with microtubule ar- 
rays. Fig. 1, A and B depict confocal indirect immunofluo- 
rescence images of a-CKI and tubulin antibody staining of 
an LLC-PK cell, respectively. The  vesicular staining of 
a-CKI could be colocalized with microtubules by image 
overlay  (Fig.  1  C).  Because  CKI  had  previously been 
shown to associate with membranes as well the detergent- 
insoluble  cytoskeleton, it  was  not  clear  whether  these 
punctate structures were membraneous vesicles or other 
components. Therefore, CKI antibodies were used to dou- 
ble-label cells with additional antibodies specific for differ- 
ent internal membrane markers. As shown in Fig. 1, D-F, 
CKI was coincident with [3-COP, a Golgi-specific marker. 
However, this colocalization was apparent only at the cell 
periphery. When cells were stained with BiP antibodies, 
an ER-specific marker, as in Fig. 1, G-l, the kinase ap- 
peared to be associated in part with the ER. This limited 
association occurred on a substructure of the ER and was 
more vesicular in morphology. Taken together, these im- 
ages  suggested that  CKI associates  with a  select mem- 
brane  population which has markers derived from both 
the ER and Golgi organelles. 
To determine whether CKI was associated with a spe- 
cific type of membrane vesicle, newborn rat prirnary neu- 
rons  derived from sympathetic ganglia were  double  la- 
beled with antibodies specific for CKI and the synaptic 
vesicle-specific proteins, synaptophysin, and SV-2 (Fig. 2). 
Colocalization of synaptic vesicle markers with CKI was 
most apparent in the axon and growth cone (Fig. 2, A-C, 
small arrows). The association of CKI with synaptic vesicle 
markers in primary neurons was less evident in the Golgi 
region (Fig. 2, A-C, large arrow). In Fig. 2, G and/, pri- 
mary neurons were double labeled with a-CKI and SV-2 
antibodies.  The  colocalization of CKI in  the  axon  and 
growth cone was one-to-one with both synaptophysin and 
SV-2  (see  Fig. 2,  G-/).  Differentiated PC-12  ceils were 
also labeled for CKI and synaptic vesicle markers. In these 
cells, CKI appeared to be coincident with synaptic vesicle 
markers, particularly along axons and in the growth cone 
(data not shown). 
The specificity of the et-CKI antibodies was previously 
established by Western blotting in all nonneuronal cells 
assayed (21).  A  Western blot (Fig. 3) of undifferentiated 
(lane A) and differentiated (lane B) PC-12 cells demon- 
strated that the et-CKI antibody specifically detected the 
36-kD CKI. The visible minor band with an apparent mo- 
lecular mass of 40 kD was likely the otL-CKI alternatively 
spliced isoform (Zhang, J., and R.  A.  Anderson, manu- 
script in preparation). To demonstrate that CKI staining in 
primary neurons particularly in the axon, was specific for 
the 36-kD  CKI, neurons were Western blotted with the 
et-CKI antibody (Fig. 3). Lane C was a lysate of rat pri- 
mary sympathetic ganglia, and lanes E and F were blots of 
the ganglia cell bodies and axons, respectively. For this ex- 
periment, ganglia were grown as an explant (cell mass) 
from which the axons radiate outward. Growing the neu- 
rons in this fashion permitted the separation of cell bodies 
from their axons. The cell bodies and axons were then lysed 
in SDS-containing sample buffer, separated by SDS-PAGE 
and Western blotted with CKI antibodies. Western blots 
of both axons and cell bodies with a-CKI antibody only 
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.
 detected a 36-kD protein, consistent with observations in 
nonneuronal cells (21). 
The 36-kD CKI Was Associated with Rat Brain 
Synaptic Vesicles 
The fact that CKI and synaptic vesicle proteins were dis- 
tributed within the cell in a similar fashion did not estab- 
lish a  direct association of the kinase with synaptic vesi- 
cles. Therefore, rat brain  synaptic vesicles were isolated 
using the method of Huttner et al. (49). During the purifi- 
cation, the content of CKI in the various membrane frac- 
tions was assessed by Western blotting equal protein loads 
with  CKI-  and  synaptophysin-specific  antibodies.  As 
shown  in  Fig.  4,  the  36-kD  CKI  immunoreactivity did 
copurify identically with synaptic vesicles. In Fig. 4, lane 
D, the cell body and nuclei (P1) contained little synapto- 
physin but had  an amount of CK! equivalent to that in 
lane  C  ($1).  These results were consistent with previous 
observations that CKI is present in the nucleus (76). After 
high speed centrifugation, little CKI was detected in the 
cytosolic fractions (lanes G and P). However, the microso- 
mal fraction (P3)  was  enriched for CKI.  This result was 
consistent  with  the  immunofluorescence data  shown  in 
Fig. 2, A-C, where CKI was observed in the cell body but 
was not coincident with synaptophysin staining. After ly- 
sis, the CKI in Ficoll-purified synaptosomes was enriched 
in synaptic vesicle-containing fractions. In addition, CKI 
cosedimented with the (LP2) high speed pellet which was 
enriched for synaptic vesicles as determined by synapto- 
physin Western blotting. Trace 36-kD CKI immunoreac- 
tivity was detected in the LP1 fraction which largely con- 
sisted of plasma membrane. 
To determine the extent of CKI's association with syn- 
aptic vesicles, vesicles were further purified by velocity su- 
crose density gradient sedimentation.  CKI from the LPz 
fraction cosedimented with small synaptic vesicles through 
the gradient as determined by Western blotting equal vol- 
umes of the gradient fractions for both CKI and SV-2 (Fig. 
5, top panel). The peak of synaptic vesicles was pooled and 
further purified by equilibrium sedimentation on a Nyco- 
denz gradient. CKI and SV-2 cosediment identically to a 
density of 1.12 g/cc (Fig. 5, bottom panel). The kinase ac- 
tivity towards phosvitin and a 52-kD synaptic vesicle-asso- 
ciated protein also correlated with CKI immunoreactivity. 
Fig. 6 is a comparison of the content of the 36-kD CKI 
on synaptic vesicles isolated by the above methods with 
the content of 36 kD CKI associated with synaptic vesicles 
isolated by the methods of Floor et al. (39, 40). Lanes A 
and B are Western blots with CKI antibody of two prepa- 
rations of synaptic vesicles isolated by the methods out- 
lined in Materials and Methods and lane C shows a West- 
ern  blot  of  synaptic  vesicles  which  were  >85%  pure, 
prepared by the methods of Floor et al. (40). When the ra- 
tio of CKI to SV-2 was assessed by quantitative Western 
blotting, these synaptic vesicles contained 2--4-fold more 
36 kD CKI than did vesicles prepared by procedures out- 
lined in  Materials  and  Methods.  The  difference in  CKI 
content of the two vesicle preparations may have been due 
to differences in vesicle population or in retention of ki- 
nase by the vesicles. However, the observation that CKI 
was retained by synaptic vesicles prepared using two dif- 
Figure 3. Western  blot analysis with tx-CKI antibodies  demon- 
strated that the antibodies  were specific for the 36-kD a-CKI. 
Lanes A and B are 50 txg of lysate from undifferentiated  and dif- 
ferentiated PC-12 cells, respectively. Lanes C, D, and E are 15 p.g 
of lysates from a total sympathetic ganglion neurons in culture, 
separated cell bodies, and separated axons, respectively. 
ferent methods further supported the contention that the 
36-kD CKI was associated with synaptic vesicles both in 
vitro and in vivo. 
In the sucrose gradient (Fig. 5, top), a large fraction of 
the total protein, including CKI and synaptic vesicle mark- 
ers, was found in the sucrose gradient pellet, which con- 
tained N-CAM, an integral plasma membrane protein (32, 
56). The CKI in the gradient pellet was not trapped in in- 
tact synaptosomes as the ratio of CKI to synaptic vesicle 
marker proteins was 3-5-fold greater (depending on the 
preparation) in the sucrose gradient pellet than in the iso- 
lated synaptosomes. Rehomogenization of the pellet, fol- 
lowed by sedimentation on a second sucrose gradient, re- 
leased only a minor fraction of the SV2 or CKI. Further 
analysis  by  Nycodenz  gradient  centrifugation  demon- 
strated  that  CKI,  SV2,  and  N-CAM  immunoreactivity 
cosedimented identically. Moreover, transmission electron 
microscopic analysis of the peak of CKI, SV2, and N-CAM 
immunoreactivity from the sucrose gradient indicated that 
there were intact synaptic vesicles present which were not 
trapped within sealed membrane structures. Furthermore, 
80-90%  of the 36-kD CKI in the sucrose gradient pellet 
was solubilized by high ionic strength extraction indicating 
that the CKI was not trapped. 
Isolation and Characterization of the Synaptic Vesicle 
Associated 36-kD CKI 
Three isoforms of CKI, with molecular masses in the 36-- 
39-kD range, have been identified in brain; two alterna- 
tively spliced isoforms of t~-CKI  (ct and txL) and a highly 
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Zhang, J., and R. A. Anderson, unpublished results). All 
three isoforms only differ in size by 2-3 kD. In addition, 
our CKI antibody, which was prepared against the eryth- 
rocyte a-CKI (21), immunocrossreacts with the I3-CKI iso- 
form as determined by Western blotting both recombinant 
proteins (unpublished results). Therefore, the kinase was 
purified from synaptic vesicles and characterized to estab- 
lish the identity of the synaptic vesicle-associated CKI. 
The  synaptic vesicle-associated  CKI was  eluted from 
the LP2 vesicle fraction with 1 M KC1, removing ~90% of 
the 36-kD CKI as quantified by Western blotting. The ex- 
tracted CKI was then purified by phosphocellulose ion ex- 
change,  as  described previously (21,  66).  Two peaks  of 
casein kinase activity eluted at 0.54  M  NaC1 and 0.72 M 
NaCI,  respectively.  Western  blotting  demonstrated that 
the first peak of activity was the 36-kD CKI which eluted 
at a similar NaC1 concentration as the erythroid and thy- 
mus a-CKI (21, 66). The second peak of casein kinase ac- 
tivity possessed  properties  indistinguishable from casein 
kinase II (76). The 36-kD CKI peak of activity was pooled 
and applied to a Superose 12 column. As shown in Fig. 7, 
two peaks of casein kinase activity eluted from the column 
with apparent masses of 230 kD and 45-50 kD. Both ki- 
nase activities phosphorylated phosvitin in preference to 
casein but only the 45-50-kD peak of kinase activity was 
immunoreactive with the a-CKI antibody. Because of its 
ability to use GTP, the 230-kD casein kinase peak was in- 
distinguishable from casein kinase II, which has been re- 
ported in synaptosomes (27, 34, 76). 
Inhibitors of CKI and casein kinase II were used to bio- 
chemically define the activity of the purified synaptic vesi- 
cle CKI. When [~/-32p]ATP was used as a phosphate do- 
nor, GTP did not inhibit activity indicating that it cannot 
be used by this kinase in the phosphotransfer reaction. Fig. 
8 demonstrates that this protein kinase is inhibited by both 
CKI-7 and CKI-8, specific inhibitors of CKI activity (28). 
The IC50 value for CKI-7 inhibition of the synaptic vesicle 
CKI is 12 ~M, somewhat lower than the value reported for 
a-CKI (78).  CKI-8 inhibits with an IC50 of 80  IxM which 
closely approximates that  reported for a-CKI  (78).  The 
CKI was also inhibited by heparin although this effect was 
substrate-specific (Fig. 8 B). Heparin inhibition has also 
been described for the thymus and erythroid ot-CKI (78). 
Like the erythroid a-CKI (6, 20), the synaptic vesicle CKI 
was potently inhibited by PIP2. Inhibition by PIP  2 is sub- 
strate-dependent as shown in Fig. 8 C for casein and phos- 
vitin. However, PIP2  inhibited the  synaptic vesicle  CKI 
more potently than the erythroid a-CKI (6, 20). 
When assayed with common CKI substrates, the synap- 
tic vesicle kinase phosphorylated human erythrocyte spec- 
trin (not shown), and preferred phosvitin as a  substrate 
over casein (Fig. 8 C). This substrate specificity appeared 
unique to a-CKIs, considering that c~-CKI expressed in E. 
coli  phosphorylates  a-casein  and  prefers  phosvitin  to 
casein as well (78, Zhang, J., and R. A. Anderson, unpub- 
lished results).  In contrast, bacterially expressed  13-CKI 
prefers both the a- and G-caseins over phosvitin (data not 
shown). In combination, these data indicated that the syn- 
aptic vesicle associated 36-kD CKI is most similar to a-CKI. 
Because  ot-CKI was  associated  with  synaptic vesicles 
and inhibited by CKI-7 and CKI-8, the phosphorylation of 
synaptic vesicle proteins by this kinase was determined. 
Using synaptic vesicles isolated by Nycodenz gradient sed- 
imentation (Fig. 9), the ATP-dependent phosphorylation 
of vesicle proteins is shown (lane A). Under these phos- 
phorylation conditions, described in Materials and Meth- 
ods, the two major protein kinases likely to be active on 
the vesicles are casein kinases I and II. To mask casein ki- 
nase II activity, [~/-32p]ATP was used as the phosphate do- 
nor (Fig. 9), in the presence of a 10-fold molar excess of 
GTP  (lane  B).  Although GTP masked activity towards 
some  minor  substrates,  the  majority of phosphorylated 
proteins were not affected. When CKI-7 was used at 20 
and 80 ~M, the phosphorylation of specific proteins was 
inhibited. Addition of CKI-8 at 80 and 320 p~M inhibited 
phosphorylation of the same protein bands. However, he- 
parin, a potent inhibitor of casein kinase II in membrane 
fractions (34), had no apparent effect on intrinsic synaptic 
vesicle protein phosphorylation under these conditions. 
To further demonstrate the specificity of these CKI in- 
hibitors, the CKI antibody was used to inhibit kinase activ- 
Figure 4. An autoradiogram of a Western blot of various subceUular fractions during the isolation of rat brain synaptic vesicles probed 
with rabbit antisera to synaptophysin (top) and affinity purified antibodies to et-CKI  (bottom). For each brain fraction, 50 p~g of protein 
was loaded unless otherwise noted and Western blotted according to the Materials and Methods. Lanes A are partially purified synapto- 
physin (0.2 p.g) and purified human erythroid a-CKI (50 ng); lanes B-P correspond to the following fractions from a synaptic vesicle pu- 
rification using the terminology in reference 49 and the Materials and Methods: B, H; C, $1; D, P1; E (15 Ixg protein), $2; F (15 p~g pro- 
tein), P2; G, $3; H, P3; L S2'; J (FicoU-purified  synaptosomes), P2'; K, F1; L, F2; M, LPfi N, LS1; O, LP2; P, LS2. 
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kinase  activity towards  soluble  substrates,  the  antibody 
does  inhibit  erythrocyte ot-CKI  activity  towards  mem- 
brane substrates  (Brockman, J.  L., and R. A. Anderson, 
unpublished  results).  In  this  assay,  the  antibodies  were 
preincubated with purified synaptic vesicles and the phos- 
phorylation was assayed as in Fig. 9. The left panel shows 
an autoradiogram of the SDS-PAGE after phosphoryla- 
tion  with  [~¢-32P]ATP with  increasing  concentrations  of 
CKI antibody; the right panel shows a corresponding auto- 
radiogram  densitometry scan  of phosphorylation in  the 
absence of antibody (B) and in the presence of 40 txg/ml of 
CKI antibody (A). Nonspecific IgG had no effect on the 
phosphorylation of synaptic vesicle proteins. When com- 
pared with the results in Fig. 9, the CKI antibody inhibited 
phosphorylation of the same synaptic vesicle proteins as 
did CKI-7 and CKI-8, demonstrating that these substrates 
were phosphorylated by the 36-kD CKI. 
Immunoprecipitation of Small Synaptic Vesicles 
Demonstrates That CKI Is on Synaptic Vesicles, the 
Major Substrates Are Associated with Synaptic 
Vesicles, and That SV2 Is a Substrate for CKI 
Even though CKI colocalizes and copurifies with synaptic 
vesicle-specific markers, this did not eliminate the possibil- 
ity that other membranes might be contributing to all or 
part of the observed immunoreactivity and kinase activity. 
In addition, some of the observed substrates for CKI could 
be  associated  with  membranes  whose  source  might  be 
other  than  synaptic  vesicle  in  origin.  To  address  these 
questions, synaptic vesicles were immunoprecipitated us- 
ing increasing amounts of a  mouse monoclonal antibody 
to  the  synaptic vesicle integral  membrane protein  SV2. 
Initially, unlabeled synaptic vesicles were immunoprecipi- 
tated in an effort to establish whether CKI was actually as- 
sociated with synaptic vesicles. The resultant washed im- 
munoprecipitate  pellets  and  corresponding  supernatants 
were Western blotted for CKI and SV2 using 125I-labeled 
Staph A protein as a means of detection. The signals were 
quantified by densitometry and -y-counting, respectively. 
As displayed in Fig. 11 A, both SV2 and CKI were equally 
depleted from the synaptic vesicle sample. In addition, the 
immunoprecipitate  pellets  were  enriched  for  both  CKI 
and SV2 (data not shown). 
Next,  synaptic  vesicles  were  phosphorylated  using 
[~/-32p]ATP under  conditions  where  CKI  should  be  the 
predominant kinase activity on vesicles (see Materials and 
Methods). All kinase activity was quenched with the addi- 
tion of EDTA to 5 mM and the vesicles were immunopre- 
cipitated with SV2 antibodies. The resultant immunoprecip- 
itate pellets and supematants were analyzed by SDS-PAGE 
and subsequent autoradiography. As shown in Fig. 11 B, 
all  but  two  of the  substrates  were  immunoprecipitated 
with  the  SV2  antibody and  no phosphorylated proteins 
were precipitated with normal mouse sera. These two sub- 
strates of 18 and 21 kD were still visible in the SV2 immu- 
noprecipitate pellet but with significantly reduced signal. 
Moreover, their signal was not visible in the SV2 immuno- 
precipitate supernatant. Subsequent experimentation sug- 
gested  that  the  loss  of 32p from these  two  substrates  is 
likely due to a dephosphorylation event occurring during 
immunoprecipitation.  Supporting  this  contention,  phos- 
phorylated synaptic vesicles quenched with EDTA and in- 
cubated in parallel with the immunoprecipitates also ex- 
hibited reduced phosphate incorporation into these 18- and 
21-kD substrates. 
Based upon the observation that one of the major sub- 
strates for CKI on synaptic vesicles was  a  diffuse 80-kD 
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Figure 5. CKI is associated with small synaptic vesicles when ana- 
lyzed by sucrose and then Nycodenz density gradient sedimenta- 
tion. The LP2 fraction from rat brain, as in Fig. 4, was washed by 
centrifugation and loaded on a sucrose gradient as outlined in the 
Materials and Methods. After sedimentation, 80 ixl of the result- 
ing  fractions  were  assayed  for a-CKI,  SV-2, and  N-CAM  by 
Western blotting. Fractions 4-9 were pooled and concentrated by 
centrifugation. This synaptic vesicle fraction was further analyzed 
by Nycodenz equilibrium sedimentation  and the resulting frac- 
tions were assayed by Western blotting with SV-2 and a-CKI an- 
tibodies  (middle panel). These fractions  were  also assayed  for 
protein kinase activity towards phosvitin (closed circles), an excel- 
lent a-CKI substrate (see Fig. 9) and the intrinsic phosphorylation 
(see Fig. 11) of the 52-kD major phosphorylated  synaptic vesicle 
protein (open circles) according to the Materials and Methods. 
The Journal  of  Cell Biology,  Volume 130. 1995  718 Figure 6. The 36-kD CKI was found on small synaptic vesicles pu- 
rified by two distinct methods.  Lanes A  and  B show Western 
blots with the a-CKI antibody of two synaptic vesicle prepara- 
tions purified according to the Materials and Methods. Lane C 
are synaptic vesicles prepared  by the method of Floor et al. (38, 
39). Lanes A-C are adjacent lanes on the same Western blot with 
the same exposure time. By immunodot blotting, all three synap- 
tic vesicle preparations  contained equal amounts of SV-2 protein 
but had a different content of the 36-kD CKI. The ratio of the 36 
kD CKI to SV-2 in lanes A and B is 2-4-fold less, respectively, 
than that associated with the vesicles in lane C. 
PIP2 Is Produced on the Plasma Membrane but Not on 
Synaptic Vesicles 
Previously, oL-CKI has been shown to be inhibited on na- 
tive membranes by PIPE (6,  20).  Additionally, when the 
membrane content of PIPE was increased,  the  affinity of 
ot-CKI for membranes was enhanced (6, 20). Since the syn- 
aptic vesicle 36-kD CKI was also inhibited by PIPE the su- 
crose gradient fractions were assayed for phosphatidylino- 
sitol 4-phosphate (PIP) 5-kinase activity and the type I and 
II PIP 5-kinases by Western blotting (7, 50). As shown in 
Fig. 12, all of the intrinsic PIP kinase activity and the ma- 
jority of type I  and II PIP kinase immunoreactivity were 
found in the gradient pellet. PIP 5-kinase activity and im- 
munoreactivity were not detected on purified synaptic ves- 
icles.  This result demonstrated that in vitro PIPE produc- 
tion occurred in plasma membrane but not synaptic vesicle 
fractions. This spatial segregation of PIPE production may 
account for the increased ratio of CKI to synaptic vesicle 
markers  in  the  plasma  membrane-containing  fractions 
compared to purified synaptic vesicles. 
Discussion 
Here we have shown that a PIPE-sensitive CKI was associ- 
ated with synaptic vesicles.  In addition, PIP  2 production 
was  restricted  to  specific  cellular  membranes  and  may 
therefore modulate cx-CKI activity only when the kinase is 
situated close to these membranes. The spatial synthesis of 
PIPE in the nerve terminal could be a mechanism to selec- 
band similar to that of SV2 in both size and appearance 
(3), we examined whether SV2 was a  substrate for CKI. 
32p-phosphorylated and  unlabeled  synaptic vesicles were 
treated  with  0.5%  Triton  X-100  to  disperse  the  vesicle 
membranes  and  then  immunoprecipitated  with  normal 
mouse sera or SV2 antibodies. The resultant immunopre- 
cipitates  were  analyzed  by  SDS-PAGE  and  autoradio- 
graphed. As shown in Fig. 11 C lane 1, no detectable phos- 
phorylated proteins were being immunoprecipitated with 
normal mouse sera.  In contrast,  a  protein  of the  size of 
SV2 is  readily  apparent  in  the  immunoprecipitate  using 
SV2 antibodies (Fig. 11 C, lane 3). Additionally, immuno- 
precipitates  with  normal  mouse  sera  or  SV2  antibodies 
were conducted in parallel on unlabeled vesicles for subse- 
quent  Western  blotting  with  the  SV2  antibody.  As  de- 
picted in Fig. 11  C, lane 5,  SV2 was immunoprecipitated 
with the SV2 antibodies.  No immunoreactive proteins of 
this mobility were observed in the normal mouse sera im- 
munoprecipitate (data not shown). The possibility existed, 
however, that the Triton solubilization rendered SV2 ac- 
cessible to another kinase or to CKI itself,  whereas, under 
more  "normal"  conditions  (i.e.,  intact  synaptic  vesicle 
membranes) it would not. Therefore, the identical proce- 
dure was undertaken  in the  absence of detergent.  How- 
ever, immediately before SDS-PAGE preparation, the im- 
munoprecipitates were treated with Triton as before with 
no observed change in the outcome. 
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Figure 7. Molecular sieve chromatography of the synaptic vesicle 
36 kD CKI. The 36-kD CKI was eluted from the rat brain LP  2 
fraction (Fig. 4) with 1 M KC1, fractionated by phosphocellulose, 
and then applied to a Superose 12 column. As two peaks kinase 
activity eluted from  the  Superose  12  column,  the  elution was 
Western blotted with ¢t-CKI antibodies (upper panel). Lane E is 
the purified erythroid cx-CKI and the peaks of kinase activity are 
noted above the Western blot. The size markers are: cx, urease 
(540 kD); b, apoferrin (443 kD); c, [~-amylase (200 kD); d, cata- 
lase (240 kD); e, alcohol dehydrogenase (150 kD); f, phosphory- 
lase B (97 kD); g, BSA (66 kD); h, ovalbumin (45 kD); i, carbonic 
anhydrase (29 kD); and j, cytochrome C (12.4 kD). 
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Figure 8.  Characterization of the purified 36-kD casein kinase I 
by inhibition with CKI-7, CKI-8, heparin,  and PIP2. The upper 
panel shows inhibition of kinase activity toward casein by CKI-7 
(triangles)  and CKI-8 (circles). The middle panel shows inhibition 
of kinase  activity toward  casein  by heparin.  The  lower  panel 
shows inhibition of kinase activity toward phosvitin (closed cir- 
cles) and casein (closed triangles)  by increasing amounts of pure 
PIP2. The data shown is the average of duplicate determinations 
with the variation shown. 
Figure 9. Inhibition of intrinsic  phosphorylation of synaptic vesi- 
cle proteins by casein kinase I inhibitors.  Synaptic vesicles  puri- 
fied by Nycodenz equilibrium sedimentation (see lane A for Coo- 
massie blue-stained SDS-PAGE) were incubated (lane B) with 
50 wM ['Y-32p]ATP  as described in Materials and Methods in the 
absence of additions. In lane C, 500 IxM GTP was added to block 
any casein kinase II activity and this was added in all of the re- 
maining lanes. In lanes D and E, 20 and 80 I~M CKI-7 was added, 
in lanes E and F, 80 and 320 ~M of CKI-8 was added, in lanes H 
and I, 1 and 10 p~g/ml heparin was added. This result was dupli- 
cated three times with two different synaptic vesicle preparations. 
tively modulate CKI activity. Thus, cytosolic vesicles may 
possess high CKI activity whereas  vesicles docked at  the 
plasma membrane would have a lower level of activity as a 
result of PIPe inhibition. 
Recent reports indicate that PIPe, as well as other prod- 
ucts of the PI cycle, play essential roles in the general pro- 
cess of vesicular trafficking (25, 45--48). For example, in S. 
cerevisiae,  a  phosphatidylinositol  3-kinase,  VPS34,  has 
been  genetically  linked  to  vesicular  trafficking,  particu- 
larly  as  concerns  vacuolar  sorting  (45-48,  69).  Another 
yeast  gene  product,  SEC14,  was  originally  isolated  as  a 
mutant  defective  in  Golgi secretory function  (25,  29).  It 
has since been established that this gene codes for a phos- 
phatidyl-inositol  transfer  protein,  the  mammalian  homo- 
log being required for the ATP-dependent priming of reg- 
ulated  neurotransmitter  secretion in PC-12 cells  (43-45). 
Additionally,  a  recent  report  by  Brown  et  al.  (23)  de- 
scribes a role for PIP2 in vesicular trafficking. They estab- 
lished that PIP2 is required  for significant ADP-ribosyla- 
tion factor (ARF)-mediated stimulation of phospholipase 
D  activity.  ARF  activation  of phospholipase  D  activity, 
the authors speculate, could then alter the topology of the 
membranes in such a  way as to allow for critical interac- 
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Figure 10.  Inhibition of CKI phosphorylation of synaptic vesicle 
proteins by antibodies specific for the et-CKI. Affinity-purified 
et-CKI antibody (IgG) was combined with 50 t~g of synaptic vesi- 
cles and then incubated on ice for 10 h. The phosphorylation was 
initiated  by addition  of 50 I~M [,/-32p]ATP in the presence of 500 
IxM GTP. The lanes contain the following: A, none; B, 5 I~g/ml;  C, 
10 ~g/ml; D, 20 Ixg/ml;  and E, 40 ~g/ml. Panels F and G show the 
laser densitometric scans of lanes A and E of the autoradiogram, 
respectively. 
tions involved in the budding, targeting, and/or fusion pro- 
cess. PIP2 may serve as a  binding intermediary for ARF, 
phospholipase D  or other factors which might actually me- 
diate  their functional interaction  (23).  Additionally,  Hay 
et al. have recently shown that a type I PIP kinase activity 
is required for the ATP-dependent step of Ca2+-regulated 
exocytosis in semi-intact PC12 cells (45, 50). The produc- 
tion of PIP2 appears not to be involved in the typical phos- 
pholipase C-dependent pathways (45). Consequently, PIP2 
production  could  be  altering  the  fusogenic properties of 
the vesicles as Brown et al. (23) have speculated or, alter- 
natively,  modulating  the  activity  of regulatory  enzymes 
such as CKI. 
In nonneuronal  cells,  CKI is  associated with vesicular 
structures that align with microtubules and overlap with a 
portion of both the endoplasmic reticulum and Golgi ap- 
paratus. These results suggest that CKI is associated with 
actively transported vesicles. To identify a specific popula- 
tion  of vesicles with which  CKI was associated,  primary 
neurons were double labeled with antibodies against both 
CKI  and  synaptic  vesicle-specific markers.  Results  indi- 
cated that there was a one-to-one correspondence between 
CKI and synaptic vesicle markers within the axon. How- 
ever, CKI was not  coincident  with these  synaptic vesicle 
markers within the Golgi region, similar to nonneuronal cells 
(Fig. 2). In addition, CKI copurified with synaptic vesicles 
as they were purified from rat brain. Finally, CKI's inter- 
action with synaptic vesicles appeared to occur by a direct 
association since two different synaptic vesicle purification 
protocols yielded vesicle fractions enriched in the  36-kD 
CKI. 
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Figure 11.  Immunoprecipitation of synaptic  vesicles established 
CKI's association  with  synaptic  vesicles, confirmed major sub- 
strates as being synaptic vesicle in origin, and identified  SV2 as a 
substrate for CKI. (A) Increasing amounts of SV2 antibody in the 
immunoprecipitation reaction equally immunodeplete both SV2 
and CKI from the synaptic vesicle preparation by an increasing 
degree.  SV2 immunoreactivity was measured by ,/-counting, and 
CKI immunoreactivity was determined by autoradiographic den- 
sitometry. All results were normalized to the control immunopre- 
cipitate  which contained no primary antibody.  (B) Lanes !  (im- 
munoprecipitate pellet) and 2 (immunoprecipitate supernatant) 
depict the resultant autoradiogram generated by the immunopre- 
cipitation  of a 32p-labeled synaptic vesicle preparation using nor- 
mal mouse sera.  Lane 1 demonstrates that no phosphorylated 
proteins were detected in the pellet. Lanes 3 (immunoprecipitate 
pellet) and 4 (immunoprecipitate supernatant) represent the im- 
munoprecipitation of a 32p-labeled synaptic vesicle sample using 
the SV2 antibody. Lane 3 contains all of the observed phosphory- 
lated proteins indicating that the major substrates are all associ- 
ated with synaptic vesicles. (C) Lanes 1-2 and 3--4 represent the 
immunoprecipitate pellets and supernatants of 32P-labeled synap- 
tic vesicles using normal mouse sera or SV2 antibodies,  respec- 
tively. As shown in lane 3, a phosphorylated protein is precipi- 
tated with the SV2 antibodies  possessing an apparent molecular 
mass of 80  kD  and  SV2  immunoreactivity,  as  determined  by 
Western blotting the immunoprecipitate pellet (lane 5). No phos- 
phorylated protein of that size was detected in the immunopre- 
cipitate pellet using normal mouse sera (lane 1). 
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Figure 12. PIP 5-kinase activity is present in the synaptic vesicle/ 
plasma membrane fraction but not on synaptic vesicles. The top 
panel depicts a Western blot of fractions from the sucrose gradi- 
ent sedimentation of the LPz membrane fraction with the type II 
PIP 5-kinase antibody and a corresponding blot of the same frac- 
tions with the synaptophysin antibody.  A portion of the type II 
PIP 5-kinase is soluble and remained at the top of the gradient. 
The remainder sedimented with the synaptosomal plasma mem- 
brane to the bottom. Western blots of the same fractions  using 
the type I PIP 5-kinase antibodies  elicited a signal only in the su- 
crose gradient pellet (top,  right panel). The lower panel demon- 
strates the PIP kinase activity in the sucrose  gradient fractions 
with (closed circles) and with out (open circles) exogenous PIP as 
substrate.  The open triangles  show a densitometric  measure of 
the  synaptophysin  from the  Western blot autoradiogram. The 
type I and II PIP 5-kinases and PIP kinase activity were not de- 
tected in the synaptic vesicle fractions  but were detected in the 
pellet fractions which contained both plasma membrane and syn- 
aptic vesicle markers. 
The biochemical properties of the synaptic vesicle 36 kD 
CKI were most similar to a-CKI. It was an extrinsic pro- 
tein  which  eluted  from synaptic vesicles with high  ionic 
strength.  The  CKI gel-filtered with an  apparent mass of 
45-50 kD close to that expected for the monomer. In addi- 
tion, the purified synaptic vesicle CKI was inhibited using 
known inhibitors  of e~-CKI.  However, there  exist differ- 
ences. Rat brain synaptic vesicle CKI was more potently 
inhibited  by  CKI-7, heparin,  and  PIP2  than  the  human 
erythroid e~-CKI as compared in parallel assays. However, 
the a-CKI antibodies did not distinguish between a-CKI 
and the synaptic vesicle CKI. Thus, the kinetic differences 
between the synaptic vesicle 36-kD CKI and e~-CKI could 
be  due  to  posttranslational  modifications  or  associated 
components, although differences in protein sequence can 
not be discounted. 
When  associated with synaptic vesicles, CKI appeared 
to be the major protein kinase activity detected on the syn- 
aptic vesicles under our assay conditions. Furthermore, a 
limited number of substrates were phosphorylated by the 
intrinsic synaptic vesicle CKI activity. These assay condi- 
tions were selective for the casein kinases. In the presence 
of excess GTP, five major protein bands were phosphory- 
lated.  32p-labeled,  immunoprecipitated  synaptic  vesicles 
contained all these observed substrates. The phosphoryla- 
tion of these proteins was inhibited by CKI-7 and CKI-8 at 
concentrations  that inhibit a-CKI in solution.  Moreover, 
c~-CKI  antibodies  inhibited  kinase  activity  towards  the 
same substrates, whereas nonspecific IgGs had no effect. 
In  an  effort  to  identify  these  substrates,  we  Western 
blotted 32p-labeled vesicles (see Materials  and Methods) 
with antibodies  to VAMP, rab3a, synapsin I, and synap- 
totagmin using an alkaline phosphatase detection method- 
ology (data not shown). None of these proteins comigrated 
with  synaptic vesicle-associated proteins phosphorylated 
by CKI. However, immunoprecipitation studies on labeled 
vesicles  identified  SV2,  a  glycosylated  synaptic  vesicle- 
associated integral membrane protein, as being one of the 
five major substrates for CKI described above. As demon- 
strated in both Figs. 10 and 11, respectively, a phosphory- 
lated protein with a mobility between 70 and 88 kD is pre- 
vented from being phosphorylated by known inhibitors of 
CKI and it can be immunoprecipitated by SV2 antibodies. 
Although cloned and sequenced, the function of SV2 re- 
mains unknown  (3).  Sequence  analysis suggests that  the 
protein  may  transport  small  molecules  or  ions  across 
membranes due to its putative twelve membrane-spanning 
regions, common to known fungal and bacterial transport- 
ers (3). If the proposed structure of SV2 is correct, there is 
only a limited amount of the protein that would be avail- 
able  as  substrate  to  an  extrinsically  associated  synaptic 
vesicle kinase  (3). However, at least three potential CKI 
phosphorylation sites do exist in SV2, residing in the cyto- 
plasmically  exposed  amino  terminus  of the  protein  and 
within the cytoplasmic loop between putative membrane- 
spanning domains 6  and 7  (3, 64,  76).  SV2 has also been 
detected in a number of different secretory cells suggest- 
ing that its putative role in the secretory process might be 
a  more general one.  CKI is a  highly conserved, essential 
activity from yeast to humans indicating that its function 
might be more universal as well (63, 76). While intriguing, 
no activity has yet been ascribed to SV2 and therefore no 
readily assayable affect of CKI's modification of this pro- 
tein  is  possible  (3).  Consequently,  such  an  endeavor re- 
mains for future investigation. 
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